Skip to content

EBITDA margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
Stryker logo
StrykerSYK
24.6%+4.7pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-3%-1.1pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
27.2%-3.0pp
Globus Medical logo
Globus MedicalGMED
26.3%+5.6pp
Alphatec Holdings logo
Alphatec HoldingsATEC
2.1%+1.1pp

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Calculated from Xtant Medical Holdings’s reported figures.

Based on trailing twelve months.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's EBITDA margin?
Xtant Medical Holdings (XTNT) reported EBITDA margin of 9.2% in Q1 2026.
How has Xtant Medical Holdings's EBITDA margin changed year-over-year?
Xtant Medical Holdings's EBITDA margin increased by 447.1% year-over-year, from -2.7% to 9.2%.
What is the long-term trend for Xtant Medical Holdings's EBITDA margin?
Over 5 years (2020 to 2025), Xtant Medical Holdings's EBITDA margin has grown at a 36.4% compound annual growth rate (CAGR), from 2.5% to 11.8%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.